Literature DB >> 12065241

Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats.

L Jonsson1, J O Skarphedinsson, G V Skuladottir, H Watanobe, H B Schiöth.   

Abstract

The central melanocortin system is involved in the regulation of food intake and body weight. In this study, we investigated the effect of a 4-week intracerebroventricular infusion of the melanocortin receptor agonist MT-II and the selective melanocortin-4 receptor antagonist HS024 on food intake and body weight homeostasis. The MT-II-treated rats ate less and lost considerably more weight than the control rats during the first week of treatment. During the second and third week, they gained weight and, by the end of the treatment period, the weight gain was similar to that of the control rats. The HS024 treatment caused hyperphagia and development of obesity during the entire period. Extensive accumulations of fat and a sixfold increase in leptin levels were observed in the HS024-treated rats, as compared with controls, after the 4-week period. Food conversion ratio, defined as body weight increase relative to weight of ingested food, was clearly increased in the HS024-treated rats, while it was lowered in the MT-II-treated rats compared with controls. The effect on food conversion ratio was transient, being greatest for both experimental groups during the first week and it was then attenuated to reach the level of controls at the end of the study. The results suggest that long-term injection of exogenous melanocortin receptor active substances may have an important transient effect on food conversion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065241     DOI: 10.1677/joe.0.1730517

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  9 in total

1.  Intracerebroventricular administration of melanotan II increases insulin sensitivity of glucose disposal in mice.

Authors:  A C Heijboer; A M van den Hoek; H Pijl; P J Voshol; L M Havekes; J A Romijn; E P M Corssmit
Journal:  Diabetologia       Date:  2005-06-22       Impact factor: 10.122

2.  Characterization of a novel melanocortin receptor-containing node in the SNS outflow circuitry to brown adipose tissue involved in thermogenesis.

Authors:  C H Vaughan; Y B Shrestha; T J Bartness
Journal:  Brain Res       Date:  2011-07-13       Impact factor: 3.252

Review 3.  The MC4 receptor and control of appetite.

Authors:  R A H Adan; B Tiesjema; J J G Hillebrand; S E la Fleur; M J H Kas; M de Krom
Journal:  Br J Pharmacol       Date:  2006-10-16       Impact factor: 8.739

4.  The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

Authors:  Ya-Xiong Tao
Journal:  Endocr Rev       Date:  2010-02-26       Impact factor: 19.871

5.  Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction.

Authors:  I Côté; Y Sakarya; N Kirichenko; D Morgan; C S Carter; N Tümer; P J Scarpace
Journal:  Can J Physiol Pharmacol       Date:  2016-10-19       Impact factor: 2.273

6.  Hyperphagia modifies FA profiles of plasma phospholipids, plasma FFA, and adipose tissue TAG.

Authors:  Gudrun V Skuladottir; Pall I Olason; Logi Jonsson; Jon O Skarphedinsson; Vedis H Eriksdottir; Palmi Th Atlason; Leifur Franzson; Helgi B Schiöth
Journal:  Lipids       Date:  2003-11       Impact factor: 1.880

7.  Agouti-related peptide and MC3/4 receptor agonists both inhibit excitatory hypothalamic ventromedial nucleus neurons.

Authors:  Li-Ying Fu; Anthony N van den Pol
Journal:  J Neurosci       Date:  2008-05-21       Impact factor: 6.167

8.  Regulatory Alterations of Energy Homeostasis in Spontaneously Hypertensive Rats (SHR).

Authors:  Nora Furedi; Alexandra Miko; Bianka Aubrecht; Balazs Gaszner; Diana Feller; Ildiko Rostas; Judit Tenk; Szilvia Soos; Marta Balasko; Andras Balogh; Marianna Pap; Erika Petervari
Journal:  J Mol Neurosci       Date:  2016-06-24       Impact factor: 3.444

9.  Intermittent MTII application evokes repeated anorexia and robust fat and weight loss.

Authors:  Yi Zhang; Renata Collazo; Yongxin Gao; Gang Li; Philip J Scarpace
Journal:  Peptides       Date:  2009-12-23       Impact factor: 3.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.